Wolverine Trading
BNGO icon

Wolverine Trading’s Bionano Genomics BNGO Stock Holding History

Wolverine Trading’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-178
Closed -$199K – 4033
2022
Q3 		$199K Buy
178
+83
+87% +$110K ﹤0.01% 3625
2022
Q2 		$82K Buy
95
+15
+19% +$15.4K ﹤0.01% 3899
2022
Q1 		$130K Sell
80
-2
-2% -$2.7K ﹤0.01% 4698
2021
Q4 		$154K Buy
82
+19
+30% +$50.8K ﹤0.01% 4876
2021
Q3 		$198K Sell
63
-151
-71% -$528K ﹤0.01% 5365
2021
Q2 		$967K Sell
214
-123
-36% -$486K ﹤0.01% 2829
2021
Q1 		$1.56M Buy
+337
New +$1.9M ﹤0.01% 2209

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Wolverine Trading's BNGO Position: Q4 2022 in Review

Wolverine Trading sold out of Bionano Genomics (BNGO) in Q4 2022, closing a stake of 178 shares — an estimated $199K sold.

Wolverine Trading first reported a position in BNGO in Q1 2021 and held it in 7 quarters. The position peaked at $1.56M in Q1 2021. 143 funds tracked by Wall St. Rank hold BNGO as of Q4 2022.

  • Wolverine Trading reported no remaining Bionano Genomics position as of Q4 2022 after selling out during the quarter.
  • Wolverine Trading sold 178 Bionano Genomics shares in Q4 2022, an estimated $199K.
  • Wolverine Trading first reported a position in Bionano Genomics in Q1 2021 and held it in 7 quarters.
  • Wolverine Trading's Bionano Genomics position peaked at $1.56M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.